Somatotype and size of elite female basketball players.

The aim of this study was to compare the somatotype and size of elite female basketball players in terms of playing position and team performance. Anthropometry and somatotype data were collected on 168 players from 14 countries before the Women's World Basketball Championship, Australia, 1994. There were 64 guards (mean +/- s: age 25.4 +/- 3.3 years, height 1.72 +/- 0.06 m, mass 66.1 +/- 6.2 kg, somatotype = 2.9-3.9-2.6), 57 forwards (age 25.2 +/- 3.8 years, height 1.81 +/- 0.06 m, mass 73.3 +/- 5.9 kg, somatotype = 2.8-3.5-3.2) and 47 centres (age 24.1 +/- 3.1 years, height 1.90 +/- 0.06 m, mass 82.6 +/- 8.2 kg, somatotype = 3.2-3.1-3.4). Mean somatotypes by position were significantly different (F = 7.73, P < 0.01). Guards had greater mesomorphy than centres and less ectomorphy than forwards and centres. When discriminant function analysis was applied to endomorphy, mesomorphy, ectomorphy, age, height and mass, only height, mass and ectomorphy entered (Wilks' lambda = 0.351, F = 31.40, P < 0.000), 70% of the variance was accounted for, and 72% of players were correctly classified. In the four top versus four bottom teams, guards were taller and more ectomorphic, forwards were taller, with lower mesomorphy and higher ectomorphy, and centres did not differ. Thus there are some differences in somatotypes by position and team placing, but the combination of height, mass and ectomorphy provide the best differentiation by position.

The effect of intramuscular iron injections on serum ferritin levels and physical performance in elite netballers.

The purpose of this study was to determine the effect of iron supplementation by intramuscular injection on both serum ferritin (SF) levels and exercise performance in iron depleted, non-anaemic elite female netballers. Fifteen iron depleted (Serum Ferritin <40 ug x L(-1). Haemoglobin >125 g x L(-1)) subjects (19+/-3 y) first performed their routine test battery: a vertical jump test, a 10s power and 5x6s repeat sprint test on a cycle ergometer and a 20m multi-stage shuttle run. Subjects were matched on the basis of height, mass, and playing position and then assigned to either a Ferritin Group (FG) or Placebo Group (PG) (single blind design). Subjects then underwent a course of 5x2ml intramuscular injections of either Ferrum H (FG) or normal saline (PG) over a period of 8-10 days before repeating the blood and physical performance tests. Five and 10 days following supplementation, SF levels in the FG increased significantly from baseline levels (P<0.05) and were also significantly greater than levels measured in the PG (P<0.01). Haemoglobin levels remained unchanged in both groups. All test scores remained unchanged from baseline values and were not different between the two groups. These results demonstrate that a course of 5x2ml intramuscular iron injections significantly increased SF concentration within 2 weeks without increasing Hb levels, but this rapid elevation did not enhance the physical performance in selected tests of iron depleted, non-anaemic athletes.